A total of 150 subjects will be recruited from the concurrent NCT01922388 study and followed up for two years. All patients will be evaluated using the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III at baseline (one week before surgery) and at 6, 12 and 24 months postoperatively.